Loading…
Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats
Aims—To examine the effects of oestradiol and testosterone on the early carcinogenic changes expressed in rat liver from the diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), partial hepatectomy (PH) model of hepatocarcinogenesis. Methods—Preneoplastic liver lesions were evaluated using immunoh...
Saved in:
Published in: | Gut 1998-01, Vol.42 (1), p.112-119 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b572t-27100dddfe00791cf72384236bd4bb0c8da9a5876aeaea66c5ac62b5941fcb853 |
---|---|
cites | |
container_end_page | 119 |
container_issue | 1 |
container_start_page | 112 |
container_title | Gut |
container_volume | 42 |
creator | Shimizu, I Yasuda, M Mizobuchi, Y Ma, Y-R Liu, F Shiba, M Horie, T Ito, S |
description | Aims—To examine the effects of oestradiol and testosterone on the early carcinogenic changes expressed in rat liver from the diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), partial hepatectomy (PH) model of hepatocarcinogenesis. Methods—Preneoplastic liver lesions were evaluated using immunohistochemical analysis of glutathione-S-transferase placental form (GST-P) expression; oestrogen and androgen receptor levels were measured by radioimmunoassay. Results—Oestradiol administration to non-castrated DEN-AAF-PH treated males resulted in a decrease in the area of GST-P positive foci, while testosterone increased the serum oestradiol level and reduced the area. In males, castration alone and castration with oestradiol replacement significantly reduced the GST-P positive area, and increased the hepatic oestrogen receptor level. In DEN-AAF-PH treated females, castration with testosterone replacement was associated with a significant increase in the GST-P positive area and the hepatic androgen receptor level. Conclusion—These findings suggest that exogenous and endogenous oestradiol can suppress chemical hepatocarcinogenesis. It appears that oestrogen receptors may be involved in the inhibition of malignant transformation of preneoplastic liver cells, while androgens and androgen receptors are involved in hepatocarcinogenesis. |
doi_str_mv | 10.1136/gut.42.1.112 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1726966</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4017419951</sourcerecordid><originalsourceid>FETCH-LOGICAL-b572t-27100dddfe00791cf72384236bd4bb0c8da9a5876aeaea66c5ac62b5941fcb853</originalsourceid><addsrcrecordid>eNp9kM1rGzEQxUVoSZw0t14DCy300nU12tXXpVDcpE0IKaVNDr0IrVay5dirrbQb0v--MjYmuQQdxPB-vHnzEHoLeApQsU_zcZjWZAp5IgdoAjUTZUWEeIUmGAMvKa_lETpOaYkxFkLCITqUFFMh2QRd_hr7PtqU_IMtrHPWDEVwRbBpiLr1YVWErjALu_ZGr4qF7fUQjI7Gd2FuO5t8KnxXRD2kN-i106tkT3f_Cbq9OP89-15e__h2OftyXTaUk6EkHDBu29ZZjLkE4zipRE0q1rR102AjWi01FZxpmx9jhmrDSENlDc40glYn6PPWtx-btW2N7XLSleqjX-v4TwXt1XOl8ws1Dw8KOGGSsWzwbmcQw98xH6qWYYxdzpwRLuVmlczUxy1lYkgpWrffAFhtele5d1UTBXkiGT97mmoP74rO-vudrlNu0kXdGZ_2GIEKiNxsLbeYT4N93Ms63ivGK07Vzd1MXdzAz69X8EdVmf-w5Zv18uWA_wFzxai3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779959419</pqid></control><display><type>article</type><title>Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats</title><source>PubMed Central</source><creator>Shimizu, I ; Yasuda, M ; Mizobuchi, Y ; Ma, Y-R ; Liu, F ; Shiba, M ; Horie, T ; Ito, S</creator><creatorcontrib>Shimizu, I ; Yasuda, M ; Mizobuchi, Y ; Ma, Y-R ; Liu, F ; Shiba, M ; Horie, T ; Ito, S</creatorcontrib><description>Aims—To examine the effects of oestradiol and testosterone on the early carcinogenic changes expressed in rat liver from the diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), partial hepatectomy (PH) model of hepatocarcinogenesis. Methods—Preneoplastic liver lesions were evaluated using immunohistochemical analysis of glutathione-S-transferase placental form (GST-P) expression; oestrogen and androgen receptor levels were measured by radioimmunoassay. Results—Oestradiol administration to non-castrated DEN-AAF-PH treated males resulted in a decrease in the area of GST-P positive foci, while testosterone increased the serum oestradiol level and reduced the area. In males, castration alone and castration with oestradiol replacement significantly reduced the GST-P positive area, and increased the hepatic oestrogen receptor level. In DEN-AAF-PH treated females, castration with testosterone replacement was associated with a significant increase in the GST-P positive area and the hepatic androgen receptor level. Conclusion—These findings suggest that exogenous and endogenous oestradiol can suppress chemical hepatocarcinogenesis. It appears that oestrogen receptors may be involved in the inhibition of malignant transformation of preneoplastic liver cells, while androgens and androgen receptors are involved in hepatocarcinogenesis.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.42.1.112</identifier><identifier>PMID: 9505896</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>2-Acetylaminofluorene ; Androgens ; Animal tumors. Experimental tumors ; Animals ; antioxidant ; Biological and medical sciences ; Biomarkers, Tumor - analysis ; Body Weight - drug effects ; Carcinogens ; Diet ; Diethylnitrosamine ; Estradiol - therapeutic use ; Experimental digestive system and abdominal tumors ; Female ; Females ; Glutathione Transferase - analysis ; glutathione-S-transferase placental form ; Growth hormones ; Growth rate ; Hepatectomy ; hormone receptor ; Immunohistochemistry ; Liver cancer ; Liver Disease ; Liver Neoplasms, Experimental - chemically induced ; Liver Neoplasms, Experimental - drug therapy ; Liver Neoplasms, Experimental - enzymology ; Male ; Males ; Medical sciences ; Microscopy ; Olive oil ; Orchiectomy ; Organ Size - drug effects ; Ovariectomy ; Rats ; Rats, Inbred F344 ; Receptors, Androgen - analysis ; Receptors, Estradiol - analysis ; Rodents ; Studies ; Testosterone ; Testosterone - therapeutic use ; Tumors ; Women</subject><ispartof>Gut, 1998-01, Vol.42 (1), p.112-119</ispartof><rights>British Society of Gastroenterology</rights><rights>1998 INIST-CNRS</rights><rights>Copyright: 1998 British Society of Gastroenterology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b572t-27100dddfe00791cf72384236bd4bb0c8da9a5876aeaea66c5ac62b5941fcb853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726966/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726966/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,4010,27904,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2131299$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9505896$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimizu, I</creatorcontrib><creatorcontrib>Yasuda, M</creatorcontrib><creatorcontrib>Mizobuchi, Y</creatorcontrib><creatorcontrib>Ma, Y-R</creatorcontrib><creatorcontrib>Liu, F</creatorcontrib><creatorcontrib>Shiba, M</creatorcontrib><creatorcontrib>Horie, T</creatorcontrib><creatorcontrib>Ito, S</creatorcontrib><title>Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats</title><title>Gut</title><addtitle>Gut</addtitle><description>Aims—To examine the effects of oestradiol and testosterone on the early carcinogenic changes expressed in rat liver from the diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), partial hepatectomy (PH) model of hepatocarcinogenesis. Methods—Preneoplastic liver lesions were evaluated using immunohistochemical analysis of glutathione-S-transferase placental form (GST-P) expression; oestrogen and androgen receptor levels were measured by radioimmunoassay. Results—Oestradiol administration to non-castrated DEN-AAF-PH treated males resulted in a decrease in the area of GST-P positive foci, while testosterone increased the serum oestradiol level and reduced the area. In males, castration alone and castration with oestradiol replacement significantly reduced the GST-P positive area, and increased the hepatic oestrogen receptor level. In DEN-AAF-PH treated females, castration with testosterone replacement was associated with a significant increase in the GST-P positive area and the hepatic androgen receptor level. Conclusion—These findings suggest that exogenous and endogenous oestradiol can suppress chemical hepatocarcinogenesis. It appears that oestrogen receptors may be involved in the inhibition of malignant transformation of preneoplastic liver cells, while androgens and androgen receptors are involved in hepatocarcinogenesis.</description><subject>2-Acetylaminofluorene</subject><subject>Androgens</subject><subject>Animal tumors. Experimental tumors</subject><subject>Animals</subject><subject>antioxidant</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Body Weight - drug effects</subject><subject>Carcinogens</subject><subject>Diet</subject><subject>Diethylnitrosamine</subject><subject>Estradiol - therapeutic use</subject><subject>Experimental digestive system and abdominal tumors</subject><subject>Female</subject><subject>Females</subject><subject>Glutathione Transferase - analysis</subject><subject>glutathione-S-transferase placental form</subject><subject>Growth hormones</subject><subject>Growth rate</subject><subject>Hepatectomy</subject><subject>hormone receptor</subject><subject>Immunohistochemistry</subject><subject>Liver cancer</subject><subject>Liver Disease</subject><subject>Liver Neoplasms, Experimental - chemically induced</subject><subject>Liver Neoplasms, Experimental - drug therapy</subject><subject>Liver Neoplasms, Experimental - enzymology</subject><subject>Male</subject><subject>Males</subject><subject>Medical sciences</subject><subject>Microscopy</subject><subject>Olive oil</subject><subject>Orchiectomy</subject><subject>Organ Size - drug effects</subject><subject>Ovariectomy</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Receptors, Androgen - analysis</subject><subject>Receptors, Estradiol - analysis</subject><subject>Rodents</subject><subject>Studies</subject><subject>Testosterone</subject><subject>Testosterone - therapeutic use</subject><subject>Tumors</subject><subject>Women</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNp9kM1rGzEQxUVoSZw0t14DCy300nU12tXXpVDcpE0IKaVNDr0IrVay5dirrbQb0v--MjYmuQQdxPB-vHnzEHoLeApQsU_zcZjWZAp5IgdoAjUTZUWEeIUmGAMvKa_lETpOaYkxFkLCITqUFFMh2QRd_hr7PtqU_IMtrHPWDEVwRbBpiLr1YVWErjALu_ZGr4qF7fUQjI7Gd2FuO5t8KnxXRD2kN-i106tkT3f_Cbq9OP89-15e__h2OftyXTaUk6EkHDBu29ZZjLkE4zipRE0q1rR102AjWi01FZxpmx9jhmrDSENlDc40glYn6PPWtx-btW2N7XLSleqjX-v4TwXt1XOl8ws1Dw8KOGGSsWzwbmcQw98xH6qWYYxdzpwRLuVmlczUxy1lYkgpWrffAFhtele5d1UTBXkiGT97mmoP74rO-vudrlNu0kXdGZ_2GIEKiNxsLbeYT4N93Ms63ivGK07Vzd1MXdzAz69X8EdVmf-w5Zv18uWA_wFzxai3</recordid><startdate>199801</startdate><enddate>199801</enddate><creator>Shimizu, I</creator><creator>Yasuda, M</creator><creator>Mizobuchi, Y</creator><creator>Ma, Y-R</creator><creator>Liu, F</creator><creator>Shiba, M</creator><creator>Horie, T</creator><creator>Ito, S</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>199801</creationdate><title>Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats</title><author>Shimizu, I ; Yasuda, M ; Mizobuchi, Y ; Ma, Y-R ; Liu, F ; Shiba, M ; Horie, T ; Ito, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b572t-27100dddfe00791cf72384236bd4bb0c8da9a5876aeaea66c5ac62b5941fcb853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>2-Acetylaminofluorene</topic><topic>Androgens</topic><topic>Animal tumors. Experimental tumors</topic><topic>Animals</topic><topic>antioxidant</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Body Weight - drug effects</topic><topic>Carcinogens</topic><topic>Diet</topic><topic>Diethylnitrosamine</topic><topic>Estradiol - therapeutic use</topic><topic>Experimental digestive system and abdominal tumors</topic><topic>Female</topic><topic>Females</topic><topic>Glutathione Transferase - analysis</topic><topic>glutathione-S-transferase placental form</topic><topic>Growth hormones</topic><topic>Growth rate</topic><topic>Hepatectomy</topic><topic>hormone receptor</topic><topic>Immunohistochemistry</topic><topic>Liver cancer</topic><topic>Liver Disease</topic><topic>Liver Neoplasms, Experimental - chemically induced</topic><topic>Liver Neoplasms, Experimental - drug therapy</topic><topic>Liver Neoplasms, Experimental - enzymology</topic><topic>Male</topic><topic>Males</topic><topic>Medical sciences</topic><topic>Microscopy</topic><topic>Olive oil</topic><topic>Orchiectomy</topic><topic>Organ Size - drug effects</topic><topic>Ovariectomy</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Receptors, Androgen - analysis</topic><topic>Receptors, Estradiol - analysis</topic><topic>Rodents</topic><topic>Studies</topic><topic>Testosterone</topic><topic>Testosterone - therapeutic use</topic><topic>Tumors</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimizu, I</creatorcontrib><creatorcontrib>Yasuda, M</creatorcontrib><creatorcontrib>Mizobuchi, Y</creatorcontrib><creatorcontrib>Ma, Y-R</creatorcontrib><creatorcontrib>Liu, F</creatorcontrib><creatorcontrib>Shiba, M</creatorcontrib><creatorcontrib>Horie, T</creatorcontrib><creatorcontrib>Ito, S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimizu, I</au><au>Yasuda, M</au><au>Mizobuchi, Y</au><au>Ma, Y-R</au><au>Liu, F</au><au>Shiba, M</au><au>Horie, T</au><au>Ito, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>1998-01</date><risdate>1998</risdate><volume>42</volume><issue>1</issue><spage>112</spage><epage>119</epage><pages>112-119</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract>Aims—To examine the effects of oestradiol and testosterone on the early carcinogenic changes expressed in rat liver from the diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), partial hepatectomy (PH) model of hepatocarcinogenesis. Methods—Preneoplastic liver lesions were evaluated using immunohistochemical analysis of glutathione-S-transferase placental form (GST-P) expression; oestrogen and androgen receptor levels were measured by radioimmunoassay. Results—Oestradiol administration to non-castrated DEN-AAF-PH treated males resulted in a decrease in the area of GST-P positive foci, while testosterone increased the serum oestradiol level and reduced the area. In males, castration alone and castration with oestradiol replacement significantly reduced the GST-P positive area, and increased the hepatic oestrogen receptor level. In DEN-AAF-PH treated females, castration with testosterone replacement was associated with a significant increase in the GST-P positive area and the hepatic androgen receptor level. Conclusion—These findings suggest that exogenous and endogenous oestradiol can suppress chemical hepatocarcinogenesis. It appears that oestrogen receptors may be involved in the inhibition of malignant transformation of preneoplastic liver cells, while androgens and androgen receptors are involved in hepatocarcinogenesis.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>9505896</pmid><doi>10.1136/gut.42.1.112</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0017-5749 |
ispartof | Gut, 1998-01, Vol.42 (1), p.112-119 |
issn | 0017-5749 1468-3288 1458-3288 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1726966 |
source | PubMed Central |
subjects | 2-Acetylaminofluorene Androgens Animal tumors. Experimental tumors Animals antioxidant Biological and medical sciences Biomarkers, Tumor - analysis Body Weight - drug effects Carcinogens Diet Diethylnitrosamine Estradiol - therapeutic use Experimental digestive system and abdominal tumors Female Females Glutathione Transferase - analysis glutathione-S-transferase placental form Growth hormones Growth rate Hepatectomy hormone receptor Immunohistochemistry Liver cancer Liver Disease Liver Neoplasms, Experimental - chemically induced Liver Neoplasms, Experimental - drug therapy Liver Neoplasms, Experimental - enzymology Male Males Medical sciences Microscopy Olive oil Orchiectomy Organ Size - drug effects Ovariectomy Rats Rats, Inbred F344 Receptors, Androgen - analysis Receptors, Estradiol - analysis Rodents Studies Testosterone Testosterone - therapeutic use Tumors Women |
title | Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T00%3A37%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppressive%20effect%20of%20oestradiol%20on%20chemical%20hepatocarcinogenesis%20in%20rats&rft.jtitle=Gut&rft.au=Shimizu,%20I&rft.date=1998-01&rft.volume=42&rft.issue=1&rft.spage=112&rft.epage=119&rft.pages=112-119&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.42.1.112&rft_dat=%3Cproquest_pubme%3E4017419951%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b572t-27100dddfe00791cf72384236bd4bb0c8da9a5876aeaea66c5ac62b5941fcb853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1779959419&rft_id=info:pmid/9505896&rfr_iscdi=true |